Corcept Therapeutics (NASDAQ:CORT) Downgraded to “Hold” Rating by StockNews.com
Corcept Therapeutics (NASDAQ:CORT – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Wednesday. Several other equities research analysts have also recently issued reports on the stock. Canaccord Genuity Group lifted their price objective on shares of Corcept Therapeutics from […]
Corcept Therapeutics (NASDAQ:CORT – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Wednesday. Several other equities research analysts have also recently issued reports on the stock. Canaccord Genuity Group lifted their price objective on shares of Corcept Therapeutics from […]
